A detailed history of Royce & Associates LP transactions in Si Bone, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 145,000 shares of SIBN stock, worth $1.97 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
145,000
Previous 145,000 -0.0%
Holding current value
$1.97 Million
Previous $2.37 Million 21.03%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$15.75 - $21.38 $204,750 - $277,940
13,000 Added 9.85%
145,000 $3.04 Million
Q1 2023

May 04, 2023

BUY
$12.71 - $21.17 $457,560 - $762,120
36,000 Added 37.5%
132,000 $2.6 Million
Q4 2022

May 23, 2023

SELL
$11.23 - $19.44 $404,280 - $699,840
-36,000 Reduced 27.27%
96,000 $1.31 Million
Q4 2022

Feb 13, 2023

BUY
$11.23 - $19.44 $325,670 - $563,760
29,000 Added 43.28%
96,000 $1.31 Million
Q3 2022

Nov 03, 2022

SELL
$12.2 - $18.71 $183,000 - $280,650
-15,000 Reduced 18.29%
67,000 $1.17 Million
Q4 2021

Feb 07, 2022

SELL
$18.75 - $24.8 $1.32 Million - $1.74 Million
-70,358 Reduced 46.18%
82,000 $1.82 Million
Q3 2021

Nov 10, 2021

SELL
$19.65 - $31.89 $1.67 Million - $2.71 Million
-85,000 Reduced 35.81%
152,358 $3.26 Million
Q2 2021

Aug 06, 2021

SELL
$29.4 - $35.96 $483,394 - $591,254
-16,442 Reduced 6.48%
237,358 $7.47 Million
Q1 2021

May 10, 2021

SELL
$28.09 - $34.02 $12.3 Million - $14.9 Million
-437,900 Reduced 63.31%
253,800 $8.07 Million
Q4 2020

Feb 08, 2021

BUY
$20.44 - $30.88 $7.4 Million - $11.2 Million
362,100 Added 109.86%
691,700 $20.7 Million
Q3 2020

Nov 12, 2020

BUY
$15.68 - $24.28 $4.16 Million - $6.44 Million
265,300 Added 412.6%
329,600 $7.82 Million
Q2 2020

Aug 07, 2020

BUY
$10.56 - $18.46 $679,008 - $1.19 Million
64,300 New
64,300 $1.03 Million

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $467M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.